IRRAflow System
External Ventricular Drainage (Hydrocephalus, ICH)
Key Facts
About IRRAS
IRRAS is a public medical device company focused on developing and commercializing innovative systems for neurosurgical and neurocritical care. Its core achievement is the IRRAflow platform, an active, automated system designed to replace passive external ventricular drains, with the goal of reducing complications and improving the standard of care. The company's strategy involves direct sales in key European markets and distributor partnerships globally, supported by regulatory clearances including FDA 510(k). IRRAS seeks to establish its technology as a new standard in intracranial fluid management.
View full company profileAbout IRRAS
IRRAS is a public medical device company focused on developing and commercializing innovative systems for neurosurgical and neurocritical care. Its core achievement is the IRRAflow platform, an active, automated system designed to replace passive external ventricular drains, with the goal of reducing complications and improving the standard of care. The company's strategy involves direct sales in key European markets and distributor partnerships globally, supported by regulatory clearances including FDA 510(k). IRRAS seeks to establish its technology as a new standard in intracranial fluid management.
View full company profileAbout IRRAS
IRRAS is a public medical device company focused on developing and commercializing innovative systems for neurosurgical and neurocritical care. Its core achievement is the IRRAflow platform, an active, automated system designed to replace passive external ventricular drains, with the goal of reducing complications and improving the standard of care. The company's strategy involves direct sales in key European markets and distributor partnerships globally, supported by regulatory clearances including FDA 510(k). IRRAS seeks to establish its technology as a new standard in intracranial fluid management.
View full company profileAbout IRRAS
IRRAS is a public medical device company focused on developing and commercializing innovative systems for neurosurgical and neurocritical care. Its core achievement is the IRRAflow platform, an active, automated system designed to replace passive external ventricular drains, with the goal of reducing complications and improving the standard of care. The company's strategy involves direct sales in key European markets and distributor partnerships globally, supported by regulatory clearances including FDA 510(k). IRRAS seeks to establish its technology as a new standard in intracranial fluid management.
View full company profile